Education
About Us
Working with TipRanks
Follow Us
RaySearch Laboratories AB Class B (SE:RAY.B)
:RAY.B
Earnings Data
Report Date
Feb 12, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.69Last Year’s EPS
1.75Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong quarter for RaySearch with record revenues, improved profitability, and significant interest in their solutions. However, challenges with cash flow and temporary high gross margins were noted. Overall, the positive developments and strategic plans for expansion into new areas like chemotherapy and surgery suggest a promising future.Company Guidance
Record High Net Sales and Improved Profitability
Q3 2025 saw record high net sales of SEK 332 million, a 13% increase, marking the highest revenue RaySearch has ever recorded. Operating profit increased by 44% to SEK 89 million, with an EBIT margin of 27%.
Strong Interest and Orders from Major Particle Centers
RaySearch secured deliveries to 6 major particle centers in Asia, contributing to strong interest in their solutions. Order intake increased by 70%, with significant expansions from existing customers.
RayIntelligence Platform Launch
RaySearch launched a new version of RayIntelligence, their oncology analytics platform, which is cloud-based and includes interactive dashboards and a powerful SQL scripting interface for data exploration.
Celebration of 25 Years and Strong Company Culture
RaySearch celebrated 25 years in business and hosted an internal conference to strengthen company culture and engagement.
New RayCare and RayStation Orders
RaySearch received new orders from Stanford Healthcare in the U.S., Keimyung University in South Korea, and saw expansions in New Zealand and Germany, among others.
Future Expansion into Chemotherapy and Surgery
RaySearch plans to integrate chemotherapy planning and management into RayStation and RayCare, with future support for surgical planning.
SE:RAY.B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:RAY.B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 07, 2025 | kr210.50 | kr256.50 | +21.85% |
Aug 08, 2025 | kr304.50 | kr300.50 | -1.31% |
May 09, 2025 | kr238.12 | kr311.39 | +30.77% |
Feb 21, 2025 | kr263.37 | kr237.13 | -9.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does RaySearch Laboratories AB Class B (SE:RAY.B) report earnings?
RaySearch Laboratories AB Class B (SE:RAY.B) is schdueled to report earning on Feb 12, 2026, Before Open (Confirmed).
What is RaySearch Laboratories AB Class B (SE:RAY.B) earnings time?
RaySearch Laboratories AB Class B (SE:RAY.B) earnings time is at Feb 12, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of RaySearch Laboratories AB Class B stock?
The P/E ratio of RaySearch Laboratories AB is N/A.
What is SE:RAY.B EPS forecast?
SE:RAY.B EPS forecast for the fiscal quarter 2025 (Q4) is 1.69.